agilon health, inc. provided revenue guidance for the first quarter ending March 31, 2024. For the quarter, the company expects total revenues of $1,605 million to $1,630 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -2.53% | -8.42% | -60.16% |
Apr. 22 | Citigroup Starts agilon health With Neutral Rating, $6 Price Target | MT |
Mar. 06 | Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.16% | 2.06B | |
-21.25% | 2.91B | |
-20.94% | 2.67B | |
-25.10% | 323M | |
-4.99% | 211M | |
-47.38% | 172M | |
-27.37% | 123M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2024